AWHP submitted comments to the CDC’s ACIP expressing its belief in the Committee’s role in upholding transparency and scientific rigor, providing the public with the latest high-
quality data on safety and effectiveness for both recommended vaccines and new vaccines in development.

AWHP sent letters to the Florida State Senate and House urging members to prioritize expanding Medicaid coverage for the full range of evidence-based, comprehensive obesity care options, including medications, for Florida residents living with obesity by supporting SB 648 and HB 713.

AWHP respectfully urged the Connecticut Legislative Black and Puerto Rican Caucus to prioritize supporting efforts to expand Medicaid coverage for the full range of evidence-based, comprehensive obesity care options, including medications, for Connecticut residents living with obesity.

AWHP submitted a testimony respectfully urging that coverage for obesity treatment in state-regulated commercial insurance and Medicaid be included in the in the State Fiscal Year 2025-26 Executive Budget.

AWHP submitted comments to the Centers for Medicare & Medicaid Services (CMS) on their recent proposal to expand coverage for obesity medications in Medicare Part D and Medicaid.

AWHP provided comments on the USPSTF’s draft guidelines on screening for cervical cancer.

AWHP submitted comments on WPSI’s draft recommendations on screening and counseling for intimate partner violence, breast cancer screening, and patient navigation services for breast and cervical cancer.

AWHP sent letters to the White House Initiative on Women’s Health Research, Senate Appropriations Committee, and House Appropriations committee urging modest additional funding for the USPSTF.

AWHP sent a letter to the Connecticut Department of Social Services urging the immediate implementation of Public Act 23-94, which establishes coverage for obesity medications and weight-loss surgery through the state’s Medicaid program.